Insider Buying: Adtalem Global Education (NYSE:CVSA) Director Purchases $897,356.60 in Stock

Adtalem Global Education Inc. (NYSE:CVSA) Director Michael Malafronte acquired 8,890 shares of the company’s stock in a transaction on Wednesday, March 11th. The shares were acquired at an average cost of $100.94 per share, for a total transaction of $897,356.60. Following the completion of the acquisition, the director owned 25,395 shares of the company’s stock, valued at approximately $2,563,371.30. The trade was a 53.86% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link.

Adtalem Global Education Trading Up 1.3%

Shares of NYSE:CVSA opened at $105.18 on Friday. The stock has a market cap of $3.63 billion, a price-to-earnings ratio of 15.45, a price-to-earnings-growth ratio of 0.89 and a beta of 0.72. The company has a debt-to-equity ratio of 0.37, a current ratio of 0.68 and a quick ratio of 0.68. Adtalem Global Education Inc. has a twelve month low of $86.97 and a twelve month high of $156.26.

Adtalem Global Education (NYSE:CVSA) last announced its quarterly earnings results on Wednesday, January 28th. The company reported $2.43 EPS for the quarter. The company had revenue of $503.39 million for the quarter. Adtalem Global Education had a net margin of 13.41% and a return on equity of 20.24%.

Analyst Ratings Changes

Several research firms have issued reports on CVSA. Weiss Ratings assumed coverage on Adtalem Global Education in a research report on Wednesday, February 25th. They set a “hold (c+)” rating on the stock. Zacks Research upgraded Adtalem Global Education from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, February 24th. Finally, Barrington Research reiterated an “outperform” rating and set a $170.00 price objective on shares of Adtalem Global Education in a research note on Monday, March 2nd. One investment analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating and one has issued a Hold rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Buy” and a consensus target price of $170.00.

About Adtalem Global Education

Adtalem Global Education (NYSE: CVSA) is a provider of higher education and workforce solutions focused primarily on programs that prepare students for professional careers in healthcare, medicine, veterinary medicine and related fields. The company operates campus-based and online degree programs, continuing professional education, clinical training and exam-preparation offerings designed to support students seeking licensure and employment in regulated professions.

Adtalem’s portfolio includes institution brands that deliver undergraduate, graduate and professional training across nursing, medicine, veterinary medicine and allied health disciplines.